ABSTRACT TTF-1/NKX2.1, also known as T/EBP, is a homeodomain-containing gene involved in the organogenesis of the thyroid gland, lung and ventral forebrain. We have already reported that in 3T3 cells, TTF-1/NKX2.1 up-regulates the transcription of nestin, an intermediate filament protein expressed in multipotent neuroepithelial cells, by direct DNA-binding to a HRE/CRE-like site (NestBS) within a CNS-specific enhancer. Here, we demonstrate that TTF-1/NKX2.1 is coexpressed with nestin in the embryonal forebrain. We also performed a transgenic mouse embryo analysis in which NestBS was replaced by the canonical TTF-1/NKX2.1 consensus DNA-binding site (as identified in many thyroid-and lung-specific genes and very divergent from NestBS) or a random mutation. We observed β β β β β-galactosidase expression in forebrain regions where TTF-1/ NKX2.1 is expressed in wild-type embryos, and -to a minor extent-in rostralmost telencephalic regions and thalamus, whereas no β β β β β-galactosidase expression was detected in forebrains of embryos bearing the random mutation. These data show that TTF-1/NKX2.1 regulates the transcription of the nestin gene in vivo through the NestBS site, suggesting that nestin might be at least one of the effectors of TTF-1/NKX2.1 during forebrain development. Finally, we have shown that the transactivating effect of TTF-1/NKX2.1 on the CNS-specific enhancer is unaffected by Retinoic Acid Receptor-α α α α α.
Introduction
TTF-1/NKX2.1, also known as T/EBP, is a homeodomaincontaining transcription factor belonging to the NKX gene family required for the tissue specific-expression of several thyroid-and lung-specific genes (Guazzi et al., 1990; Missero et al., 1998; Whitsett et al., 1998) . TTF-1/NKX2.1 is also expressed in restricted areas of the developing forebrain, namely in the diencephalon (i.e., in the hypothalamus) and in the telencephalon (i.e., in the medial ganglionic eminence, preoptic area, and anterior endopeduncular area) (Lazzaro et al., 1991; Price et al., 1992; Sussel et al., 1999) . In addition, TTF-1/NKX2.1 is one of the genes involved in the early organization of the vertebrate rostral brain, playing a role in the early patterning of the developing head in longitudinal and transverse domains (Rubenstein et al., 1998; Shimamura et al., 1995; Wilson and Rubenstein, 2000) . A subset of precursor cells expressing TTF-1/NKX2.1 migrates tangentially from the medial ganglionic eminence of the ventral telencephalon to the developing striatum and to the developing cortical plate (Marìn and Rubenstein, 2001; Anderson et al., 2001) . TTF-1/NKX2.1 expression in the adult persists in the hypothalamus and in the subfornical organ, a circumventricular organ of the third ventricle (Lee et al., 2001; Son et al., 2003) . TTF-1/NKX2.1 homozygous mutant mice were born dead and lacked completely the thyroid gland and the lung parenchyma, the entire pituitary was missing, and extensive defects were found in the THE INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY www.intjdevbiol.com ventral region of the forebrain (Kimura et al., 1996) . It has also been reported that in TTF-1/NKX2.1 knockout mice a ventral-to-dorsal transformation of the pallidum primordium into a striatal-like anlage takes place (Sussel et al., 1999) .
Since in TTF-1/NKX2.1 K.O. mice the organogenesis of the ventral forebrain is profoundly perturbed, elucidating the mechanisms by which TTF-1/NKX2.1 is able to play its fundamental role in the development of the forebrain might be important to achieve a better comprehension of brain organogenesis. In order to better elucidate the function of TTF-1/NKX2.1 in the developing forebrain, we performed an analysis of brain-specific TTF-1/NKX2.1 target genes, and we found that TTF-1/NKX2.1 ectopic expression in fibroblastic cells strongly up-regulates the endogenous transcription of the neuroepithelial cell marker nestin, by direct DNA-binding to an already characterized enhancer capable of recapitulate the CNS-specific expression of the nestin gene in transgenic mice (Lonigro et al., 2001; Zimmerman et al., 1994) . TTF-1/NKX2.1 bound to the CNS-specific enhancer through a NestBS site, already known by transgenic mice analysis to be essential for proper nestin expression in the telencephalic portions of the forebrain from 12.5 d.p.c onwards (Josephson et al., 1998) . In this study, we have exploited the role of TTF-1/NKX2.1 in the in vivo regulation of the nestin gene transcription analyzing transgenic mouse embryos in which the NestBS site was replaced by a random mutation or by the canonical TTF-1/ NKX2.1 consensus DNA-binding site, previously identified in many thyroid-and lung-specific regulatory DNA sequences (Damante et al., 1994; Bohinski et al., 1994) . In this way, if TTF-1/NKX2.1 is indeed the protein binding to the nestin gene in vivo, presumably it would be still able to recognize a mutation bearing the canonical TTF-1/NKX2.1 DNA-binding site, but not a random mutation. Moreover, since it has been reported that Retinoic Acid Receptor (RAR)-α was able to bind in vitro to the NestBS sequence (Lothian et al., 1999) and the surfactant protein-B promoter-stimulation by retinoic acid was dependent on juxtaposed RAR-α and TTF-1/NKX2.1 sites (Naltner et al., 2000) , we tested the hypothesis that an interplay occurs between these two transcription factors in the context of the nestin enhancer.
Results
TTF-1/NKX2.1 and nestin are co-expressed in murine embryonal brain
As a first step, in order to elucidate if TTF-1/NKX2.1 plays a role in the regulation of the nestin gene in vivo, we assessed if TTF-1/NKX2.1 and nestin were actually co-expressed in the murine developing forebrain. To this aim, we performed a double immunohistochemistry staining for TTF-1/NKX2.1 and nestin protein on forebrain sections from wild type 14 d.p.c. mouse. As shown in Fig. 1A , we found that TTF-1/NKX2.1 and nestin were co-expressed, respectively, in the nucleus and in the cytoplasm of the majority of the cells within the domain of expression of TTF-1/NKX2.1. In order to quantify this expression, we also performed immunofluorescence (IF) assays on cells dissociated from whole E14 mouse brains with antibodies against TTF-1/NKX2.1 and nestin, and the nuclei were visualized by DAPI staining. Again, a clear nuclear signal for TTF-1/ NKX2.1 was observed, while the anti-nestin antibody showed a cytoplasmic signal (Fig. 1B) . However, cells positive for TTF-1/NKX2.1 were often found in clusters, suggesting that they derived either from rapidly dividing cells in the overnight cell culture or from dissociation of tightly linked embryonal cells. Therefore, we performed a flow cytometric analysis (i.e., without any previous plating step) on freshly dissociated cells from murine E14 brains using the same antibodies against TTF-1/ NKX2.1 and nestin used in IF assays: we found that about 18% of the total cells were positive for TTF-1/NKX2.1, 65% for nestin and 15% were double positive. Remarkably, ∼ 83% of the TTF-1/NKX2.1-expressing cells were also positive for nestin (Fig. 1C) .
TTF-1/NKX2.1 is able to recognize a mutagenized NestBS site when replaced by a DNA-binding site bearing its core recognition sequence 5'-CAAG-3', and not by a random sequence, in co-transfection assay
We have previously shown that TTF-1/NKX2.1 in 3T3 cells is able to transactivate a CNS-specific enhancer of the nestin 
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gene through direct DNA binding to a NestBS site similar to HRE/CRE, bearing a 5'-TGAGGTCA-3' core sequence (Lonigro et al., 2001) . We then compared the basal transcriptional activity of this enhancer in two different cell lines of neural (Neuro2A) or non-neural (NIH3T3) origin by transfection of the previously described luciferase reporter construct pNes-Luc, bearing the CNS-specific enhancer (Lonigro et al., 2001) . We found that the basal activity of the enhancer was more efficient (4.5-fold higher) in the neural rather than in the non-neural cells, and that it was able to impart a tissue-specific expression to the luciferase reporter gene in cell culture (Fig. 2) .
In transgenic mice bearing the core recognition sequence of NestBS mutagenized to 5'-GTAGGCCT-3', the β-gal expression was shown to be virtually absent in the telencephalon in comparison with the rest of the CNS, suggesting that this element was critical for proper nestin telencephalic expression in vivo from 12.5 to at least 14.5 d.p.c of mouse development (Josephson et al., 1998) . Therefore, we replaced the wild-type site within the NestBS sequence of the pNes-Luc construct with two different mutations in order to obtain two mutagenized constructs: the first (pNes.mut-Luc) bearing a random sequence identical to the DNA sequence used by Josephson et al. (1998) for the generation of transgenic mice described above (5'-GTAGGCCT-3'), the second (pNes.OligoC-Luc) bearing the DNA-binding site of TTF-1/NKX2.1 (5'-GTCAAGTG-3') found within the rat thyroglobulin promoter (OligoC, from Civitareale et al., 1989) . The latter mutagenized pNes.OligoCLuc construct contained the canonical 5'-CAAG-3' consensus core sequence of the TTF-1/NKX2.1 protein, as identified in many thyroid-and lung-specific genes (Fig. 3A) . Noticeable, only 4 out of 8 base pairs of the wild-type NestBS site were substituted in the pNes.mut-Luc construct, whereas 8 out of 8 bp were replaced in pNes-OligoC-Luc. We then evaluated whether the mutagenized constructs were able to differentially influence the extent of the transactivation mediated by the TTF-1/NKX2.1 protein. Since, to our knowledge, a cell line of neural origin expressing TTF-1/NKX2.1 was not available, we co-transfected the reporter constructs (pNes.mut-Luc, pNes.OligoC-Luc, and the wild-type pNes-Luc) with or without an expression vector encoding for TTF-1/NKX2.1 (pCMV-TTF1) in 3T3 cells (Fig. 3A) . We found that the wild-type pNesLuc reporter construct showed a ∼2.5-fold increase in transcriptional activity when co-transfected with pCMV-TTF1 (as reported in Lonigro et al., 2001) , whereas the pNes.mut-Luc failed to show a clear increase, and the pNes.OligoC-Luc showed a ∼3.4-fold increase, suggesting that the random mutation negatively affects the transactivation mediated by TTF-1/NKX2.1, while the mutation containing the TTF-1/NKX2.1 canonical DNA-binding site does not (Fig. 3B) . Therefore, these data suggest that TTF-1/NKX2.1 protein is still able to In order to test whether the mutation in NestBS containing the TTF-1/NKX2.1 canonical DNAbinding site present in the pNes.OligoC-Luc construct is recognized in vivo by the endogenous TTF-1/NKX2.1 protein in E13 mouse embryos, transgenic mouse embryos were generated carrying the same three NestBS sites described above (one wild-type and two mutated either randomly or with the 5'-CAAG-3' core sequence). The CNS-specific enhancer of the nestin II intron containing the wild-type or either one of the two mutated NestBS sites were inserted upstream of a β-globin minimal promoter driving the expression of a LacZ reporter gene. The three obtained constructs (called pNes-LacZ, pNes.mut-LacZ and pNes.OligoC-LacZ, respectively) were introduced into fertilized FVBxFVB mouse eggs by pronuclear injection. The resulting mouse embryos were harvested and analyzed for lacZ expression by whole-mount β-galactosidase (β-Gal) histochemistry (Fig. 4) . As previously reported (Zimmerman et al., 1994; Josephson et al., 1998) , E13 transgenic mouse embryos bearing the pNes-LacZ construct showed β-Gal staining along the entire length of the CNS (Fig. 4) .
TRANSGENIC EMBRYO ANALYSIS OF THE CNS-SPECIFIC ENHANCER OF THE NESTIN GENE CONTAINING A WILD-TYPE OR A MUTATED NESTBS
Whole-mount β-Gal staining of transgenic embryos bearing the pNes.mut-LacZ or pNes.OligoC-LacZ constructs showed the presence of a signal in the entire neural tube in roughly 30% of the total embryos analyzed, with the notable exclusion of the telencephalic portions (Fig. 4 and Table 1 ). However, in 6 out of 7 (∼86%) of the pNes.OligoC-LacZ-bearing embryos a faint staining was also detected in the rostralmost telencephalic regions. In addition, in 5 out of 7 (71%) of the pNes.OligoC-LacZ transgenic embryos an ectopic expression in whisker pad primordia was also present (Fig. 4 and Table 1 ). To better identify the CNS regions displaying the β-Gal staining, 125 µM thick transverse sections were obtained from E13 forebrains of transgenic mice bearing the three constructs. Forebrains of transgenic mice bearing the pNes.OligoC-LacZ construct showed an intense staining in the medial ganglionic eminence and hypothalamus (Fig. 5 A,B) , not observed in pNes.mutLacZ-bearing embryos (Fig. 5F ). However, a strong expression in the thalamus was also observed, not present in the pNes.mutLacZ-bearing mice or in the domains of expression of the wild type TTF1/NKX2.1 protein (Fig. 5B) . Moreover, a faint but clear β-Gal expression was present in the rostralmost regions of the cortical plate, as already suggested by whole-mount β-Gal staining (Fig. 4D ). For comparison, a similar transverse section from a transgenic mouse bearing a pNes-Luc construct (containing a wt CNS-specific enhancer) showed β-Gal expression in the telencephalic vesicles, medial ganglionic eminence and hypothalamus (Fig. 5E ). More posterior CNS regions, i.e. mesencephalon (Fig. 5B) and prospective spinal cord (data not shown), showed the same β-Gal expression pattern with all the three constructs. Remarkably, all the regions strongly expressing TTF-1/NKX2.1 within the CNS during mouse development are positive for lacZ expression (Price et al., 1992; Sussel et al., 1999) , with the sole exception of the more ventral regions of the hypothalamus, in which no β-Gal expression was observed (Fig. 5 B,C, arrows) .
Finally, in order to demonstrate that TTF-1/NKX2.1 and β-Gal actually co-exists in the same cell/s of transgenic embryos, we performed a double immunostaining on forebrain sections of E13 pNes.OligoC-LacZ-expressing embryos: at high magnification a clear co-localization was shown with two antibodies recognizing the β-Gal and the TTF-1/NKX2.1 proteins (in the cytoplasm and nucleus, respectively) in the hypothalamus (Fig.  6A ) and in the medial ganglionic eminence (Fig. 6B) .
The transactivating effect of TTF-1/NKX2.1 on the CNS-specific enhancer is unaffected by Retinoic Acid Receptor-α α α α α
Several recombinant nuclear hormone receptors known to control important events during development (i.e., TRs, RXR, RAR-α, and COUP-TF) are able to bind in vitro to HRE/CRE-like (=NestBS) sequences (Lothian et al., 1999) . Moreover, it has been shown that retinoic acid stimulation of the human surfactant protein B promoter is dependent on both Retinoic Acid Receptor-α (RAR-α) and TTF-1/NKX2.1 binding elements strictly juxtaposed among them, and that TTF-1/NKX2.1 and RAR-α directly interact in two hybrid system assay (Naltner et al., 2000) . To test whether TTF-1/NKX2.1 and RAR-α also interact in the context of the CNS-specific enhancer of the nestin gene, we co-transfected in 3T3 cells the pNes-Luc reporter construct together with the TTF-1/NKX2.1-encoding pCMV-TTF1 vector, and/or pSG-RAR-α, encoding for RAR-α (Fig. 7) . The analysis of the luciferase activity showed that pCMV-TTF1 alone induced a ∼3-fold activation over the basal activity of pNes-Luc alone (as previously reported), whereas pSG-RAR-α caused a negligible increase. However, when the two nuclear factors were transfected to- gether, they failed to show any synergistic or even additional effect on the extent of transcription of the reporter gene, suggesting that the transactivating activity of TTF-1/NKX2.1 on the CNSspecific enhancer of the nestin gene was unaffected by RAR-α (Fig. 7) .
Discussion
We have previously shown that TTF-1/NKX2.1 is able to activate the transcription of the CNS-specific enhancer in the second intron of the nestin gene in 3T3 cells (Lonigro et al., 2001 ). Here we provide evidence that the same transactivation is indeed achieved in vivo in the developing mouse embryos. Immunohistochemistry and immunofluorescence assays shows that TTF-1/NKX2.1 and nestin are co-expressed in the same cell population: in fact, in E13 wild type mouse embryos and in cells dissociated from brains of E14 mouse embryos, most of the TTF-1/NKX2.1-expressing cells are also positive for nestin (Fig.1) . EMSA assays Price et al., 1992) . A similar discrepancy is also observed in thyroid, where TTF-1/NKX2.1 elicits tissue-specific expression of the thyroglobulin and thyroperoxidase genes only from 14 d.p.c. onwards, even if the protein is already present from 9 d.p.c. (Lazzaro et al., 1991) . For the above mentioned thyroid-specific promoters, it has already been shown that down-regulation of a thyroid-specific repressor (TTF-2) between E13 and E15 is the major event leading to a complete transcriptional activation mediated by TTF-1 in conjunction with Pax8, another thyroid-specific nuclear factor (Zannini et al., 1997) . It might be conceivable that, also in the case of the CNS-enhancer, either a relief from a concurrent negative regulation or a positive interaction of other factor/s with TTF-1/ NKX2.1 is necessary to achieve a complete transcriptional activity of the nestin gene.
Finally, the extent of the transactivation with TTF-1/NKX2.1 alone is, as already reported, not very high, suggesting that other factors present in the proper cellular environment are required for a full expression of the nestin gene. Therefore, since RAR-α is able to bind in vitro to NestBS (Lothian et al., 1999) and also to establish a protein-protein interaction with TTF-1 in the context of another tissue-specific promoter (Naltner et al., 2000) , we co-transfected in 3T3 cells TTF-1/NKX2.1 and RAR-α in order to find a synergistic or additional effect of the two proteins on the CNS-specific enhancer of the nestin gene, but we did not observe it. We are going to try other nuclear hormone receptors (in particular, 9-cis-retinoic receptor RXR, thyroid hormone receptor and chicken ovalbumin upstream promoter transcription factor COUP-TF) already shown to bind to the CNS-specific enhancer in order to see a cooperation or even a protein-protein interaction with TTF-1/NKX2.1.
In conclusion, we have demonstrated that in transgenic mouse embryos endogenous TTF-1/NKX2.1 is co-expressed with nestin, it is able to recognize its canonical DNA-binding site in the context of the CNS-specific enhancer of the nestin gene and to drive β-galactosidase reporter gene expression in TTF-1/NKX2.1-expressing regions, suggesting that TTF-1/NKX2.1 -in conjunction with other transcription factors binding to distinct sites within the same enhancer-regulates the transcription of the nestin gene in the developing embryo in these regions. These data suggest that nestin might be at least one of the effectors through which TTF-1/ NKX2.1 plays its pivotal role in the organogenesis of the forebrain.
Materials and Methods

Construction of reporter plasmids
To obtain pNes-LacZ construct we amplified with GL2.1 (5'-GTATCTTATGGTACTGTAACT-3') and LUC-XN3' (5'-ATCCTCTAGAGGATAGAATGGCGCCGGG-3') oligonucleotides the pNes.Luc construct already described (Lonigro et al., 2001 ) to obtain a 415 bp-long DNA fragment (containing also ∼60 bp from the luciferase gene coding sequence in its 3'-portion). This 415-bp-long fragment was cut with SmaI and XbaI and the resulting 380-bp long fragment cloned in NotI (filledin) and SpeI sites of the pGS-100 LacZ-containing reporter plasmid, a modified version of the pBGZ40 vector (Yee and Rigby, 1993) , kindly provided by S. Brunelli. The NestBS site was mutagenized by polymerase chain reaction (PCR) with the above mentioned GL2.1 and LUC-XN3' oligonucleotides and the mismatched primers 5'-AGAGGAGTAGGCCTTCGGCCTTGGCCTTGG-3' to obtain the pNes.mutLacZ construct, and with the mismatched primers 5'-CCAGAGGAGTCAAGTGTCGGCCTTGGCCTT-3' to obtain the pNes.OligoC-LacZ construct. The amplified fragments were cloned in the pGS-100 vector as described for pNes.LacZ. performed with NestBS oligonucleotide and nuclear extracts prepared from E14 mouse brains already showed that TTF-1/NKX2.1 does not bind to NestBS if mutagenized into a random sequence (Lonigro et al., 2001) . These data are here confirmed and extended by co-transfection assays in 3T3 cells demonstrating that the TTF-1/NKX2.1-mediated transactivation of the nestin gene is abolished by a randomly mutagenized NestBS (pNes.mut-Luc), while it is still present if NestBS is replaced by TTF-1/NKX2.1 canonical DNArecognition site (5'-GTCAAGTG-3'), even if the wild-type NestBS displays a completely different DNA sequence (5'-TGAGGTCA-3'). Thereof, we generated transgenic mouse embryos carrying a construct bearing the canonical DNA-binding site of TTF-1/NKX2.1 (or a random sequence) in the NestBS site within the CNSenhancer of the nestin gene. Transgenic mice analysis showed that the endogenous TTF-1/NKX2.1 protein is still able to recognize its DNA-recognition site in the mouse embryo and, consequently, to restore a β-galactosidase expression in TTF-1/NKX2.1-expressing regions, which instead remains abolished in transgenic embryos bearing a random mutation of the same site. On the contrary, β-Gal staining in telencephalic districts where TTF-1/ NKX2.1 is not expressed (i.e., most of the telencephalic vesicles) is absent in pNes.OligoC-LacZ-bearing embryos as in pNes.mutLacZ-bearing embryos, suggesting that the activity of NestBS cannot be fully replaced by the DNA-binding site consensus for TTF-1/NKX2.1, and that other NestBS-binding factor/s are needed for nestin expression in these telencephalic regions. In addition, as expected, the reporter gene expression driven by the two mutagenized constructs is indistinguishable in more posterior regions of the neural tube (i.e., mesencephalon, rhombencephalon and spinal cord), suggesting that NestBS does not influence nestin expression in these districts and that other factors binding to other DNA-binding sites within the CNS-enhancer (see also Josephson et al., 1998) are necessary for proper nestin expression along the more posterior neural tube. Similarly, more ventral hypothalamic regions are devoid of β-Gal expression, suggesting that other transcription factors are needed, either alone or in conjunction with TTF-1/NKX2.1, to achieve a proper nestin expression in other developing diencephalic regions.
On the other hand, we found in pNes.OligoC-LacZ-bearing embryos a β-Gal signal in two nestin-expressing regions of active cellular proliferation where no TTF-1/NKX2.1 expression has ever been described: the thalamus and -even if at a minor extent -in a subset of the most rostral part of the telencephalic vesicles (Fig.  5D) , where lacZ expression resembles radial glial cells, previously shown to express nestin during development (Dahlstrand et al., 1995) . These findings might be explained by the presence in these two forebrain regions of factor/s (possibly belonging to the NK2 gene family) still able to recognize the CNS-specific enhancer when it bears the TTF-1/NKX2.1 recognition site, but not the randomly mutated NestBS. However, we cannot rule out a more simple ectopic effect: in fact, lacZ expression also in the whisker pad primordium is strongly associated with the expression in the basal forebrain, suggesting that it is probably due to an ectopic recognition of the exogenous DNA-sequence by factor/s present in this region. Josephson and co-authors (1998) have shown that the mutation in the HRE (=NestBS) site had detectable effects only from 12.5 d.p.c. onwards, but the TTF-1/NKX2.1 protein is present in the developing forebrain already from 9 d.p.c. on (Lazzaro et al., 1991;  To obtain the pNes.mut-Luc and pNes.OligoC-Luc construct, the pNes.mut-LacZ and pNes.OligoC-LacZ constructs were cut with SacI and BglII endonucleases and the resulting 271 bp-fragment was cloned in the SacI and BglII sites of the pGL2-Enhancer vector (Promega).
Immunofluorescence assays and flow cytometric analysis
For immunofluorescence assays, whole brains from E14 embryos were mechanically dissociated, plated, cultured overnight and fixed as previously described (Guazzi et al., 2003) . Cells were then incubated for 10 min at room temperature with 0.1% Triton-X in 0.1 M phosphate buffer, pH 7.4 (PBS), blocked in 2% bovine serum albumin in PBS incubated for 1 hour with a purified anti-TTF1 rabbit polyclonal antibody, a kind gift from R. Di Lauro's lab (1:1000) and with a mouse monoclonal antibody raised against rat nestin (1:500; Pharmingen, USA). After extensive washing in PBS+0.1 mg/ml bovine serum albumin, donkey TRITC-coupled anti-rabbit and FITC-coupled anti-mouse immunoglobulins secondary antibodies from Jackson Laboratories (1:200) were used for visualization. For flow cytometric analysis, cells were dissociated as described above, aliquots of 10 6 cells were directly immunostained (without any plating procedure) as described above, and fluorescence signals were collected using a FACScalibur (Becton Dickinson. USA).
Cell culture and co-transfection Assays
Neuro-2A cells were grown in DMEM+10%FCS+ 2mM L-Glutamine in humidified atmosphere, 5% CO2 at 37°C and NIH 3T3 cells were cultured as previously described (Lonigro et al., 2001) . 5 µg of the reporter constructs pNes.Luc, pNes.mut-Luc and pNes.OligoC-Luc (described above) were co-transfected with 0.25 µg of pCMV-TTF1, a mammalian expression vector encoding for TTF1/NKX2.1 (De Felice et al., 1995) , or with the empty expression vector in 6 cm culture dishes by standard Ca + / phosphate method. Data were normalized by co-transfection with an expression vector for β galactosidase (pPGK-β gal) and standard β-gal assay. The pSG-RAR-α vector, encoding for RAR-α, was a gift from P. Chambon. All transfections were carried out in duplicate batches in at least three separate experiments.
Generation of transgenic mice, whole-mount β β β β β-gal procedure and immunohistochemistry Transgenic mouse embryos were generated by pronuclear microinjection of fertilized eggs from FVBxFVB crosses and implantation in CD1 foster mothers. All the embryos were harvested, washed in PBS and fixed in cold 2% paraformaldehyde, 0.1% glutaraldehyde in PBS for 15 min. Embryos were washed three times in cold PBS for 15 min and stained with 1 mg/ml X-Gal, 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 . H 2 O, 2 mM MgCl 2 , 0.02% NP-40, 0.01% Na-deoxicholate in PBS at 37°C for 2-6 hours. Embryos were then washed extensively with PBS at room temperature and post-fixed with 4% paraformaldehyde in PBS for storage at 4°C. Embryos positive for β-Gal staining were then washed three times in PBS for 10 min at room temperature, included in 2% agarose in PBS and sectioned with a vibratome in 125 µM thick transverse sections. Double immunohistochemistry experiments were performed with the same polyclonal antibody used for the IF assay (anti-TTF-1) and either a mouse monoclonal antibody against beta-galactosidase (Zymed, San Francisco, USA) or the mouse monoclonal anti-nestin (Pharmingen), using the "PicTure Double Immunohistochemistry Kit" from Invitrogen, USA following the manufacturer's instructions.
